Making Sense of Novartis and GlaxoSmithKline's Web of Deals

Now watching

Next video starts in : 7 Play

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

Making Sense of Novartis and GlaxoSmithKline's Web of Deals
Replay video
Up next

SoBe Apologizes For 'Help Me' Message

Unlock your personal NFL Now stream by signing in to NFL.com

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

by TheStreet.com Videos 1:26 mins

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

by TheStreet.com Videos 1:26 mins

The pharmaceutical industry had a deluge of M&A activity on Tuesday as heavyweights Novartis and GlaxoSmithKline announced they were trading $20 billion worth of assets. Novartis will purchase GSK's oncology portfolio for $14.5 billion, strengthening its number two spot in the specialty. Meanwhile, GSK will purchase Novartis' vaccines unit for $5.25 billion. The two companies will also form a separate consumer healthcare business in which GSK will hold a 63.5% majority stake.

Must Watch

Other Space

  1. 27:05

    Other Space Episode 1: Into the Great Beyond...Beyond

  2. 25:20

    Other Space Episode 2: Getting to Know You

  3. 25:51

    Other Space Episode 3: The Death of A.R.T.

  4. 25:46

    Other Space Episode 4: Ted Talks

  5. 26:44

    Other Space Episode 5: Trouble's Brewing

  6. 27:02

    Other Space Episode 6: Powerless

Other Space

  1. 27:05

    Other Space Episode 1: Into the Great Beyond...Beyond

  2. 25:20

    Other Space Episode 2: Getting to Know You

  3. 25:51

    Other Space Episode 3: The Death of A.R.T.

  4. 25:46

    Other Space Episode 4: Ted Talks

  5. 26:44

    Other Space Episode 5: Trouble's Brewing

  6. 27:02

    Other Space Episode 6: Powerless